Dr. Benjamin Thomas Gielda, MD

Dr. Gielda practices at Corewell Health Lakeland Hospitals - Saint Joseph Hospital in Saint Joseph, Michigan, part of Corewell Health.

Dr. Gielda's NPI, 1386801496, was assigned on May 18, 2008. Dr. Gielda graduated from University of Michigan Medical School in 2006. Dr. Gielda holds Michigan license 4301101556.

Dr. Gielda's primary practice is Corewell Health Lakeland Hospitals - Saint Joseph Hospital, at 1234 Napier Avenue, Saint Joseph, MI 49085 in Berrien County. The practice phone is (269) 983-8300.

Dr. Gielda's primary practice is Corewell Health Lakeland Hospitals - Saint Joseph Hospital in Saint Joseph, Michigan, part of Corewell Health. Dr. Gielda is also affiliated with Corewell Health Watervliet Hospital. The medical group on file is Corewell Health Medical Group South. Dmand AI also links Dr. Gielda to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gielda practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Gielda's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Gielda's licenses on file in 2 states: Michigan and Illinois.

CMS data shows 1,762 Medicare services from Dr. Gielda across 18 procedure codes in 2024, for 270 Medicare patients. Medicare paid $129,165 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 270 Medicare patients who saw Dr. Gielda in 2024. The largest group is 65 to 74, with 124 patients. 75% of them have cancer, and 71% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gielda's median patient age at 71, with 45% women.

In 2024, Dr. Gielda wrote 204 Medicare Part D claims for 70 patients. 96% of them were for generic drugs. CMS names the drug for 96 of them, across 5 drugs with 11 or more claims each, at $1,768 in total drug cost. In 2023, CMS named 93 claims across 5 drugs.

Dr. Gielda accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Dr. Gielda, published from 2009 to 2020. 2010 was the busiest year, with 2. The most frequent topics are Feasibility Studies, Radiotherapy Dosage and Carcinoma, Non-Small-Cell Lung. Dr. Gielda has published most often in Med Dosim. Dr. Gielda's most frequent co-authors are Philip D. Bonomi, MD, Mary J. Fidler, MD and Michael L. Liptay, MD.

CMS Open Payments shows 27 general payments to Dr. Gielda from 13 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 67% of the total. Carl Zeiss Meditec, Inc. paid the most, $1,480.

Dr. Gielda graduated from University of Michigan Medical School in 2006.